Used primarily as a biomarker for monitoring the metabolism and detoxification of cyclophosphamide, a chemotherapy agent. It helps assess patient exposure and metabolic clearance, supporting dose optimization in cancer therapy. Its presence in urine indicates the breakdown of cyclophosphamide, aiding in evaluating treatment efficacy and potential toxicity risks.